87 studies found for:    MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Sumatriptan+Promethazine (SPr)
22 Completed Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Other: Sham chiropractic manipulative therapy;   Other: Chiropractic spinal manipulative therapy
23 Completed Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Laxymig ER (drug)
24 Completed Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Placebo;   Drug: Eletriptan HBr 40 mg;   Drug: Eletriptan HBr 80 mg
25 Completed Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg
26 Completed Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg;   Drug: Sumatriptan 25 mg;   Drug: Sumatriptan 50 mg
27 Completed Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg;   Drug: Sumatriptan 50 mg;   Drug: Sumatriptan 100 mg
28 Completed Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 20 mg;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg
29 Completed Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Maxalt 10mg MLT plus Caffeine 75mg;   Drug: Maxalt 10mg MLT plus Placebo;   Drug: Placebo + Placebo
30 Completed Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Dronabinol MDI
31 Completed Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
32 Completed Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
33 Completed Randomized Controlled Trial of Treating Migraine With Acupuncture
Condition: Migraine
Intervention: Other: acupuncture
34 Recruiting Open-trial on the Prevention of Chronic Migraines With the CEFALY Device
Condition: Migraine
Intervention: Device: CEFALY
35 Recruiting Randomized Controlled Trial on Acute Treatment of Migraine With the Cefaly® Device
Condition: Migraine
Interventions: Device: CEFALY Active;   Device: CEFALY Placebo
36 Completed
Has Results
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
Condition: Migraine
Interventions: Drug: Telcagepant potassium 150 mg;   Drug: Telcagepant potassium 300 mg;   Drug: Zolmitriptan 5 mg;   Drug: Placebo to telcagepant 150 mg;   Drug: Placebo to tecagepant 300 mg;   Drug: Placebo to zolmitriptan 5 mg;   Drug: Rescue medication
37 Completed
Has Results
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
Condition: Migraine
Interventions: Drug: placebo;   Drug: ibuprofen;   Drug: acetominophen;   Drug: telcagepant
38 Completed Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without
Conditions: Migraine;   Headaches
Interventions: Drug: 100 mg Sumatriptan Tablet and OPTINOSE Placebo delivered nasally;   Drug: OPTINOSE SUMATRIPTAN delivered nasally and placebo tablet
39 Unknown  Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
Conditions: Migraine With Aura;   Migraine Without Aura;   Chronic Migraine
Intervention: Other: Brain MRI
40 Completed Impact of a Nurse for Migraine Management: the IMPACT Project
Conditions: Migraine Without Aura;   Migraine With Aura;   Chronic Migraine
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.